Citations

Showing 10 of 108135 citations.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression
Investigators, The Parkinson Study Group SURE-PD3, Bluett, Brent , Togasaki, Daniel M., Mihaila, Dragos, Evatt, Marian L., Rezak, Michael, Jain, Samay , Schwarzschild, Michael A. , Ascherio, Alberto, Casaceli, Cindy, Kamp, Cornelia , Lungu, Codrin , Oakes, David , Rudolph, Alice, Shoulson, Ira , Scott, B.L. , Gauger, Lisa, Aldred, Jason , Bixby, Melissa, Ciccarello, Jill, Gunzler, Steven A. , Henchcliffe, Claire , Brodsky, Matthew , Keith, Kellie, Hauser, Robert A. , LeDoux, Mark S. , Hinson, Vanessa K. , Kumar, Rajeev , Hunter, Christine , Christine, Chadwick W. , Daley, Aaron, Leehey, Maureen A. , Marcaida, Joy Antonelle de, Hung, Albert Y. , Bwala, Grace, Simon, David K. , Simuni, Tanya , Poon, Cynthia , Schiess, Mya C. , Park, Ariane , Peterson, Carolyn, Criswell, Susan R. , Durphy, Jennifer, Shill, Holly A. , Mehta, Shyamal H. , Deik, Andres , Fang, John Y., Stover, Natividad , Zhang, Lin , Dewey, Richard B. , Gerald, Ashley, Boyd, James T. , Houston, Emily , Suski, Valerie, Mosovsky, Sherri, Cloud, Leslie , Shah, Binit, James, Raymond , Zauber, S. Elizabeth , Reich, Stephen G. , Langhammer, April, LaFaver, Kathrin , Kaminski, Patricia L. , Goudreau, John L. , Russell, Doozie, Houghton, David , LaRoche, Ashley , Thomas, Karen , McGraw, Martha, Mari, Zoltan, Blindauer, Karen, Rabin, Marcie, Kurlan, Roger, Morgan, John C. , Ainslie, Melissa, Bódis-Wollner, Iván , Waters, Cheryl , Ratel, Amber Servi, Beck, Christopher A. , Bolger, Patrick, Callahan, Katherine F., Crotty, Grace F. , Klements, David , Kostrzebski, Melissa, McMahon, Gearoid M. , Pothier, Lindsay , Hauser, Robert A , Simuni, Tanya , Investigators, The Parkinson Study Group SURE-PD3, Curhan, Gary C. , Fitzgerald, Rebecca, Macklin, Eric A. , Marek, Kenneth , Mozaffarian, Dariush , Videnovic, Aleksandar , Goetz, Christopher G. , Espay, Alberto J. , Jimenez‐Shahed, Joohi , Friedman, Joseph H. , Litvan, Irene , Chou, Kelvin L. , Bhatti, Danish , Rosenthal, Liana S. , Ahmed, Anwar E. , Saint‐Hilaire, Marie , Shprecher, David , Pahwa, Rajesh , LeWitt, Peter A. , Kaminski, Patricia, Thomas, Karen, Serrano, Carmen , Soileau, Michael J , Schneider, Ruth B. , Waikar, Sushrut S. , Lang, Anthony E. , Mestre, Tiago

Mayo Clinic

JAMA | September 14, 2021 | Volume: 326 | Issue: 10 | Pages: 926

10.1001/jama.2021.10207 | PMID 34519802 Get It

Technical Note: Clinical modeling and validation of breast tissue expander metallic ports in a commercial treatment planning system for proton therapy
Kang, Yixiu, Shen, Jiajian , Hu, Yanle , Ding, Xiaoning, Bues, Martin , Shen, Jiajian , Liu, Wei

Mayo Clinic

Medical Physics | September 14, 2021 | Volume: 48 | Issue: 11 | Pages: 7512-7525

10.1002/mp.15225 | PMID 34519357 Get It

AbstractPurposeTo validate breast tissue expander metallic port (MP) models in a commercial treatment planning system (TPS) in proton pencil beam scanning (PBS) treatments for breast cancer patients with breast tissue expanders.Methods and materialsThree types of MPs taken out of a Mentor CPX4, a Natrelle 133, and a PMT Integra breast tissue expanders and a 650 cc saline filled Mentor CPX4 expander were placed on top of acrylic slabs, and scanned using a Siemens Somatom Definition AS Open RT CT scanner. Structure templates for each of the MPs were designed within Eclipse TPS. The CT numbers for the metallic parts were overridden to reflect measured or calculated relative proton stopping powers (RPSPs). Mock targets were contoured in acrylic to represent postmastectomy chest‐wall radiation therapy (PMRT) targets. Plans with different beam incident angles were optimized using the Eclipse TPS to deliver uniform prescription dose to the target using Hitachi Probeat‐V PBS beams. Eclipse calculated doses and an in‐house Monte Carlo (MC) code calculated doses were compared to the measured Gafchromic EBT3 film doses in acrylic.ResultsTPS/MC and film dose comparison results showed that (1) 3%/2 mm/10% threshold Gamma pass rates were better than 90.8% in the acrylic target region for all plans; (2) comparing TPS and film doses for the individual beam plans in the MP dose shadow areas, the area with dose difference above 5% ([ΔA] 5%) ranged from 1.1 to 5.0 cm2, and the maximum dose difference ([ΔD] 0.01 cm2) ranged from 12.5% to 25.0%; (3) comparing MC and film doses for the individual beam plans in the MP dose shadow areas, the (ΔA) 5% varied from 1.1 to 2.9 cm2 and (ΔD) 0.01 cm2 varied from 8.5% to 24.2%; (4) for a plan composed of three individual beams treating through the Mentor CPX4 expander, the TPS (ΔA) 5% was less than 0.13 cm2, and the (ΔD) 0.01 cm2 was less than 6% in the MP dose shadow areas.ConclusionsIt is feasible to treat patients with tissue expanders using multiple PBS beams using a structure template with CT number overridden to represent the measured/calculated RPSP for MPs for PBS treatment planning. MC dose was more accurate than analytical dose in the areas with high dose gradient caused by the density heterogeneity of the breast tissue expander MPs.
Generating spiral gradient waveforms with a compact frequency spectrum
Pipe, James G. , Borup, Daniel D.

Mayo Clinic

Magnetic Resonance in Medicine | September 14, 2021 | Volume: 87 | Issue: 2 | Pages: 791-799

10.1002/mrm.28993 | PMID 34519379 Get It

PurposeTo generate efficient gradient waveforms for spiral MRI which mitigate the high‐frequency attenuation inherent in gradient systems.Theory and MethodsSpiral MRI has many clinical advantages, including high temporal and SNR efficiency. One of the challenges for robust spiral MRI is a high sensitivity to imperfections in the gradient system, which requires some form of correction in order to map data correctly in k‐space. A previous numerical algorithm for generating spiral gradient waveforms was modified to reduce its high‐frequency content with minimal increase in waveform duration.ResultsExamples are shown of compact frequency gradient waveforms. Software implementing the algorithm is made available.ConclusionAn algorithm to produce gradient waveforms with a compact frequency spectrum is described. This algorithm results in greatly reduced overall error and better compatibility with gradient systems than the original algorithm from which it was derived.
Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn?
Staessens, Senna , Brinjikji, Waleed , Doyle, Karen , Vanacker, Peter , Andersson, Tommy , Doyle, Karen M , Andersson, Tommy , De Meyer, Simon F , Staessens, S , François, Olivier

Mayo Clinic

Stroke | September 14, 2021 | Volume: 52 | Issue: 11 | Pages: 3718-3727

10.1161/strokeaha.121.034289 | PMID 34517770 Get It

The composition of ischemic stroke thrombi has gained an increasing amount of interest in recent years. The implementation of endovascular procedures in standard stroke care has granted researchers the unique opportunity to examine patient thrombus material. Increasing evidence indicates that stroke thrombi are complex and heterogenous, consisting of various biochemical (eg, fibrin, von Willebrand Factor, and neutrophil extracellular traps) and cellular (eg, red blood cells, platelets, leukocytes, and bacteria) components. This complex composition may explain therapeutic limitations and also offer novel insights in several aspects of stroke management. Better understanding of thrombus characteristics could, therefore, potentially lead to improvements in the management of patients with stroke. In this review, we provide a comprehensive overview of the lessons learned by examining stroke thrombus composition after endovascular thrombectomy and its potential relevance for thrombectomy success rates, thrombolysis, clinical outcomes, stroke etiology, and radiological imaging.
Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
D’Antonio, Fabrizia , Kane, Joseph , Ibáñez, Agustín , Lewis, Simon J.G. , Camicioli, Richard , Wang, Huali , Yu, Yueyi , Ji, Yong , Kandadai, Rukmini Mridula , Ikeda, Manabu , Group, the ISTAART Lewy body dementias Consortia Working, Lewis, Simon J G , Ibañez, Agustín , Zhang, Jing , Borda, Miguel Germán , Babiloni, Claudio , Bonanni, Laura , Boeve, Bradley F. , Leverenz, James B. , Aarsland, Dag , Group, the ISTAART Lewy body dementias Consortia Working

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | September 14, 2021 | Volume: 13 | Issue: 1 | Pages: No page available

10.1002/dad2.12235 | PMID 34541289 Get It

Abstract Dementia with Lewy bodies (DLB) research has seen a significant growth in international collaboration over the last three decades. However, researchers face a challenge in identifying large and diverse samples capable of powering longitudinal studies and clinical trials. The DLB research community has begun to focus efforts on supporting the development and harmonization of consortia, while also continuing to forge networks within which data and findings can be shared. This article describes the current state of DLB research collaborations on each continent. We discuss several established DLB cohorts, many of whom have adopted a common framework, and identify emerging collaborative initiatives that hold the potential to expand DLB networks and diversify research cohorts. Our findings identify geographical areas into which the global DLB networks should seek to expand, and we propose strategies, such as the creation of data‐sharing platforms and the harmonization of protocols, which may further potentiate international collaboration.
The Efficacy of Renal Replacement Therapy for Rewarming of Patients in Severe Accidental Hypothermia—Systematic Review of the Literature
Mendrala, Konrad , Kosiński, Sylweriusz , Podsiadło, Paweł , Pasquier, Mathieu , Paal, Peter , Mazur, Piotr , Darocha, Tomasz , Mazur, Piotr K , Podsiadło, Paweł

Mayo Clinic

International Journal of Environmental Research and Public Health | September 13, 2021 | Volume: 18 | Issue: 18 | Pages: 9638

10.3390/ijerph18189638 | PMID 34574562 Get It

Background: Renal replacement therapy (RRT) can be used to rewarm patients in deep hypothermia. However, there is still no clear evidence for the effectiveness of RRT in this group of patients. This systematic review aims to summarize the rewarming rates during RRT in patients in severe hypothermia, below or equal to 32 °C. Methods: This systematic review was registered in the PROSPERO International Prospective Register of Systematic Reviews (identifier CRD42021232821). We searched Embase, Medline, and Cochrane databases using the keywords hypothermia, renal replacement therapy, hemodialysis, hemofiltration, hemodiafiltration, and their abbreviations. The search included only articles in English with no time limit, up until 30 June 2021. Results: From the 795 revised articles, 18 studies including 21 patients, were selected for the final assessment and data extraction. The mean rate of rewarming calculated for all studies combined was 1.9 °C/h (95% CI 1.5–2.3) and did not differ between continuous (2.0 °C/h; 95% CI 0.9–3.0) and intermittent (1.9 °C/h; 95% CI 1.5–2.3) methods (p > 0.9). Conclusions: Based on the reviewed literature, it is currently not possible to provide high-quality recommendations for RRT use in specific groups of patients in accidental hypothermia. While RRT appears to be a viable rewarming strategy, the choice of rewarming method should always be determined by the specific clinical circumstances, the available resources, and the current resuscitation guidelines.
ATS Core Curriculum 2021. Adult Sleep Medicine: Sleep Apnea
Jamil, Shazia , Shafazand, Shirin , Dudley, Katherine A., Lipford, Melissa C. , Gu, Chenjuan , Jun, Jonathan C. , Budnick, Isadore M. , Davis, Eric M. , Stanley, Jeffrey J. , Quaney, Rachel, Young, Kirsten, Sullivan, Shannon, McSparron, Jakob I. , Wang, Tisha , Guzman, Elizabeth, Çoruh, Başak , Jamil, Shazia M , Kent, David , Kent, David T. , Stewart, Nancy H. , Hayes, Margaret M.

Mayo Clinic

ATS Scholar | September 13, 2021 | Volume: 2 | Issue: 3 | Pages: 484-496

10.34197/ats-scholar.2021-0027re | PMID 34667995 Get It

Abstract The American Thoracic Society Sleep Core Curriculum updates clinicians on important sleep topics, presented during the annual meeting, and appearing in summary here. This year’s sleep core theme is sleep-disordered breathing and its management. Topics range from pathophysiological mechanisms for the association of obstructive sleep apnea (OSA) and metabolic syndrome, surgical modalities of OSA treatment, comorbid insomnia and OSA, central sleep apnea, and sleep practices during a pandemic. OSA has been associated with metabolic syndrome, independent of the role of obesity, and the pathophysiology suggests a role for sleep fragmentation and intermittent hypoxia in observed metabolic outcomes. In specific patient populations, surgical treatment modalities for OSA have demonstrated large reductions in objective disease severity compared with no treatment and may facilitate adherence to positive airway pressure treatment. Patient-centered approaches to comorbid insomnia and sleep apnea include evaluating for both OSA and insomnia simultaneously and using shared-decision making to determine the order and timing of positive airway pressure therapy and cognitive behavioral therapy for insomnia. The pathophysiology of central sleep apnea is complex and may be due to the loss of drive to breathe or instability in the regulatory pathways that control ventilation. Pandemic-era sleep practices have evolved rapidly to balance safety and sustainability of care for patients with sleep-disordered breathing.
Interventions for intermittent exotropia
Pang, Yi, Gnanaraj, Lawrence, Gayleard, Jessica, Han, Genie, Hatt, Sarah R, Pang, Yi, Gnanaraj, Lawrence, Gayleard, Jessica, Han, Genie, Hatt, Sarah R

Mayo Clinic

Cochrane Database of Systematic Reviews | September 13, 2021 | Volume: 2021 | Issue: 9 | Pages: No page available

10.1002/14651858.cd003737.pub4 | PMID 34516656 Get It

Discerning the Role of Autoimmunity and Autoantibodies in Epilepsy
Gillinder, Lisa , Rickett, Kirsty , Härtel, Günter , Higdon, Lindsay M., French, Jacqueline A. , Britton, Jeffrey, French, Jacqueline , Steriade, Claude , Britton, Jeffrey W.

Mayo Clinic

JAMA Neurology | September 13, 2021 | Volume: 78 | Issue: 11 | Pages: 1383

10.1001/jamaneurol.2021.3113 | PMID 34515743 Get It